BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8580557)

  • 1. Leukemia developing after 131I treatment for thyroid cancer in a patient with Werner's syndrome: molecular and cytogenetic studies.
    Takemoto Y; Hata T; Kamino K; Mitsuda N; Miki T; Kawagoe H; Ogihara T
    Intern Med; 1995 Sep; 34(9):863-7. PubMed ID: 8580557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia after iodine-131 treatment for thyroid disorders.
    Laurenti L; Salutari P; Sica S; Piccirillo N; Zini G; Zollino M; Leone G
    Ann Hematol; 1998 Jun; 76(6):271-2. PubMed ID: 9692815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute leukemias after treatment with radioiodine for thyroid cancer.
    Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
    Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute lymphoblastic leukemia with t(4;11)(q21;q23) after iodine-131 treatment for thyroid cancer].
    Iuchi Y; Sato K; Jimbo J; Inamura J; Shindo M; Ikuta K; Shinzaki H; Ohnishi K; Watanabe S; Torimoto Y; Kohgo Y
    Rinsho Ketsueki; 2005 Nov; 46(11):1202-7. PubMed ID: 16440804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myeloid leukemia after treatment with 131 for thyroid carcinoma.
    Wang KL; Lin LY; Chen PM; Lin HD
    J Chin Med Assoc; 2005 May; 68(5):230-3. PubMed ID: 15909729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
    Shimon I; Kneller A; Olchovsky D
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Four cases of hematologic malignancy following radioactive iodine therapy for thyroid cancer].
    Im M; Lee JK; Hong YJ; Hong SI; Kang HJ; Na II; Ryoo BY; Cheon GJ; Lee HN; Chang YH
    Korean J Lab Med; 2008 Dec; 28(6):425-9. PubMed ID: 19127106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute promyelocytic leukaemia following radioiodine therapy.
    Richards EM; Marcus RE
    Clin Lab Haematol; 1993; 15(1):55-8. PubMed ID: 8472497
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myelodysplastic syndrome with multiple chromosome aberrations in a patient with Werner's syndrome].
    Mita M; Ishibashi T; Shichishima T; Maruyama Y
    Rinsho Ketsueki; 1996 Aug; 37(8):725-30. PubMed ID: 8827885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preleukemia following large dose radioiodide therapy for metastatic thyroid carcinoma.
    Yoosufani Z; Slavin JD; Hellman RM; Sethi SS; Spencer RP
    J Nucl Med; 1987 Aug; 28(8):1348-50. PubMed ID: 3612295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Werner's syndrome associated with malignancies: five case reports with a survey of case histories in Japan.
    Sato K; Goto M; Nishioka K; Arima K; Hori N; Yamashita N; Fujimoto Y; Nanko H; Ohara K; Ohara K
    Gerontology; 1988; 34(4):212-8. PubMed ID: 3053337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with Werner's syndrome and erythroleukemia: just coincidence?
    Bartal C; Yerushalmi R; Zilberman D; Yermiyahu T
    Leuk Lymphoma; 1996 May; 21(5-6):509-13, color plate XXI following 5. PubMed ID: 9172819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia after treatment with 131I for thyroid carcinoma. Report of a case and review of the literature.
    Walgraeve D; Verhoef G; Stul M; Cassiman JJ; Mecucci C; Van den Berghe H; Boogaerts M
    Cancer Genet Cytogenet; 1991 Sep; 55(2):217-24. PubMed ID: 1933823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myeloid leukemia in a man with papillary carcinoma of the thyroid treated with radioactive iodine.
    Pavithran K; Doval DC
    Am J Clin Oncol; 2005 Apr; 28(2):216. PubMed ID: 15803020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighing shadows: can meta-analysis help define the risk-benefit ratio of RAI treatment for low-risk thyroid cancer patients?
    Schneider AB; Viana MA; Ron E
    Thyroid; 2009 May; 19(5):435-6. PubMed ID: 19415992
    [No Abstract]   [Full Text] [Related]  

  • 16. The beginnings of radioiodine therapy of metastatic thyroid carcinoma: a memoir of Samuel M. Seidlin, M. D. (1895-1955) and his celebrated patient.
    Siegel E
    Cancer Biother Radiopharm; 1999 Apr; 14(2):71-9. PubMed ID: 10850290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ph+ acute lymphoblastic leukemia after iodine-131 treatment for thyroid cancer.
    Piccirillo N; Sorà F; Laurenti L; Sica S; Chiusolo P; Leone G
    Haematologica; 1999 Nov; 84(11):1050-1. PubMed ID: 10553170
    [No Abstract]   [Full Text] [Related]  

  • 18. [Association of a papillary cancer with lymphocytic thyroiditis in an 18-year-old girl].
    Codaccioni JL; Depieds R; Jean R; Kleisbauer JP; Payan H
    Ann Endocrinol (Paris); 1968; 29(6):747-54. PubMed ID: 5757241
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukemia after 131I treatment of thyroid cancer--comments on the article 'Second cancer following chemotherapy and radiotherapy--an epidemiological perspective' by J. Kaldor.
    Advani SH; Hege UP
    Acta Oncol; 1992; 31(1):65. PubMed ID: 1586507
    [No Abstract]   [Full Text] [Related]  

  • 20. Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
    Sawka AM; Thabane L; Parlea L; Ibrahim-Zada I; Tsang RW; Brierley JD; Straus S; Ezzat S; Goldstein DP
    Thyroid; 2009 May; 19(5):451-7. PubMed ID: 19281429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.